Risk of diabetes mellitus among users of immune checkpoint inhibitors: A population-based cohort study.
Jeffrey Shi Kai ChanSharen LeeDicken KongIshan LakhaniKenrick NgEdward Christopher DeePias TangYan Hiu Athena LeeDanish Iltaf SattiWing Tak WongTong LiuGary TsePublished in: Cancer medicine (2023)
Users of ICI may have a substantial risk of new-onset DM, which may be higher in males but did not differ between PD-1i and PD-L1i.